Your browser doesn't support javascript.
loading
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Ishikawa, Emi; Yokoyama, Yuta; Chishima, Haruna; Kasai, Hidefumi; Kuniyoshi, Ouki; Kimura, Motonori; Hakamata, Jun; Nakada, Hideo; Suehiro, Naoya; Nakaya, Naoki; Nakajima, Hideo; Ikemura, Shinnosuke; Kawada, Ichiro; Yasuda, Hiroyuki; Terai, Hideki; Jibiki, Aya; Kawazoe, Hitoshi; Soejima, Kenzo; Muramatsu, Hiroshi; Suzuki, Sayo; Nakamura, Tomonori.
Affiliation
  • Ishikawa E; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan.
  • Yokoyama Y; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan. yokoyama-yt@pha.keio.ac.jp.
  • Chishima H; Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, 105-8512, Tokyo, Japan. yokoyama-yt@pha.keio.ac.jp.
  • Kasai H; Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, 105-8512, Tokyo, Japan.
  • Kuniyoshi O; Laboratory of Pharmacometrics and Systems Pharmacology, Keio Frontier Research and Education Collaboration Square (K-FRECS) at Tonomachi, Keio University, Kawasaki, Kanagawa, Japan.
  • Kimura M; Department of Pharmacy, Ageo Central General Hospital, Ageo, Japan.
  • Hakamata J; Department of Pharmacy, Keio University Hospital, Tokyo, Japan.
  • Nakada H; Department of Pharmacy, Keio University Hospital, Tokyo, Japan.
  • Suehiro N; Department of Pharmacy, Keio University Hospital, Tokyo, Japan.
  • Nakaya N; Department of Pharmacy, Keio University Hospital, Tokyo, Japan.
  • Nakajima H; Department of Oncology, Ageo Central General Hospital, Ageo, Japan.
  • Ikemura S; Department of Oncology, Ageo Central General Hospital, Ageo, Japan.
  • Kawada I; Department of Respiratory Medicine, Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Yasuda H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Terai H; Health Center, Keio University, Yokohama, Japan.
  • Jibiki A; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kawazoe H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Soejima K; Keio Cancer Center, School of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Muramatsu H; Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, 105-8512, Tokyo, Japan.
  • Suzuki S; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan.
  • Nakamura T; Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, 105-8512, Tokyo, Japan.
Invest New Drugs ; 41(1): 122-133, 2023 02.
Article in En | MEDLINE | ID: mdl-36637703
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ATP Binding Cassette Transporter, Subfamily B / ErbB Receptors / ATP Binding Cassette Transporter, Subfamily B, Member 2 / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ATP Binding Cassette Transporter, Subfamily B / ErbB Receptors / ATP Binding Cassette Transporter, Subfamily B, Member 2 / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2023 Document type: Article Affiliation country: Country of publication: